Market closed
Matinas BioPharma Holdings Inc./$MTNB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Matinas BioPharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Ticker
$MTNB
Sector
Trading on
AMEX
Industry
Biotechnology
Headquarters
Employees
32
Website
MTNB Metrics
BasicAdvanced
$3M
-
-$4.52
1.61
-
Price and volume
Market cap
$3M
Beta
1.61
52-week high
$0.61
52-week low
$0.47
Average daily volume
34K
Financial strength
Current ratio
5.528
Quick ratio
5.082
Long term debt to equity
14.785
Total debt to equity
19.463
Interest coverage (TTM)
-7,337.00%
Management effectiveness
Return on assets (TTM)
-54.63%
Return on equity (TTM)
-108.57%
Valuation
Price to book
0.19
Price to tangible book (TTM)
0.2
Price to free cash flow (TTM)
-0.16
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
-7.91%
3-year earnings per share growth (CAGR)
-7.55%
MTNB News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Matinas BioPharma Holdings Inc. stock?
Matinas BioPharma Holdings Inc. (MTNB) has a market cap of $3M as of April 16, 2025.
What is the P/E ratio for Matinas BioPharma Holdings Inc. stock?
The price to earnings (P/E) ratio for Matinas BioPharma Holdings Inc. (MTNB) stock is 0 as of April 16, 2025.
Does Matinas BioPharma Holdings Inc. stock pay dividends?
No, Matinas BioPharma Holdings Inc. (MTNB) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Matinas BioPharma Holdings Inc. dividend payment date?
Matinas BioPharma Holdings Inc. (MTNB) stock does not pay dividends to its shareholders.
What is the beta indicator for Matinas BioPharma Holdings Inc.?
Matinas BioPharma Holdings Inc. (MTNB) has a beta rating of 1.61. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.